Zobrazeno 1 - 10
of 365
pro vyhledávání: '"Percutaneous aortic valve replacement"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luigi Biasco, Enrico Cerrato, Gregorio Tersalvi, Giovanni Pedrazzini, Ben Wilkins, Francesco Faletra, Enrico Ferrari, Stefanos Demertzis, Gaetano Senatore, Angelo Di Leo, Ferdinando Varbella, Ole De Backer, Luis Nombela Franco
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Background: Following the success of the first human transcatheter aortic valve replacement (TAVR) in 2002, multiple transcatheter heart valves (THVs) have become available. However, guidelines or expert consensus on how to optimize THV choice accord
Externí odkaz:
https://doaj.org/article/9a7f077bfddf403dac0c9578aff64ef1
Autor:
Jérôme Petit, Laurianne Le Gloan, Ali Houeijeh, Alban-Elouen Baruteau, Julien Plessis, Robin Le Ruz, Clément Karsenty, François Godart, Karine Warin Fresse, Sébastien Hascoët, Patrice Guérin
Publikováno v:
Catheterization and Cardiovascular Interventions. 98:990-999
Objectives This study sought to investigate patient intermediate-term outcomes after transcatheter pulmonary valve replacement (TPVR) with Edwards SAPIEN valve. Background The Edwards SAPIEN valve, initially designed for percutaneous aortic valve rep
Publikováno v:
Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 19:30-41
A systematic review of the literature was conducted to analyze the results of studies evaluating the link between frailty and depression before percutaneous aortic valve replacement (TAVR) and vital prognosis and quality of life after TAVR. The liter
Publikováno v:
JACC Case Reports
This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0fe23bbc0f18d89c0ed82fe47d1359
https://hdl.handle.net/20.500.14017/f71a40f5-475d-49fb-b4ea-05fd06269375
https://hdl.handle.net/20.500.14017/f71a40f5-475d-49fb-b4ea-05fd06269375
Autor:
Florian Leuschner, Manju Guha, Andreas Hagendorff, Kurt Bestehorn, Axel Schlitt, Robert Michael Nechwatal
Publikováno v:
Herz. 46:41-47
With increasing age valvular heart disease is among the most frequent diseases of the heart. Relevant valvular disease impairs not only the long-term prognosis but also physical resilience, activities of daily living and the quality of life. In cases
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
About one in seven elderly patients with severe calcific aortic stenosis (AS) also have ATTR amyloid cardiomyopathy (AC-TTR). The reasons for this close association are not fully known, but the two entities are not only related by common epidemiology
Autor:
Evangelos Tzolos, Marc R. Dweck
Publikováno v:
Heart (British Cardiac Society). 107(17)
Calcific aortic stenosis (AS) is the most common form of valvular heart disease in the Western world, and its healthcare burden is expected to double over the next 50 years.1 Currently, no medical therapy has demonstrated an ability to slow or halt p
Autor:
Philipp Jud, Martin Eibisberger
Publikováno v:
Deutsches Ärzteblatt international.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.